Target intelligence / Profile preview

Hypoxic Tumor Cell DNA

Molecular classification: DNA, Genomic Material

Overview

Hypoxic tumor cell DNA refers to the genetic material within tumor cells that are exposed to low oxygen (hypoxic) conditions. Hypoxia drives genomic instability, impairs DNA repair pathways, and contributes to therapy resistance in cancer. It influences the activity of DNA damage response proteins like ATM, ATR, and DNA-PKcs, while inhibiting homologous recombination and non-homologous end joining.

Biological functions

Genetic information storageReplicationTranscriptionMutationDNA damage response

Disease associations

CancerTherapy resistance

Safety considerations

Genomic instabilityTherapy resistance

Beyond the preview

Go deeper on Hypoxic Tumor Cell DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hypoxic Tumor Cell DNA.

Explore the full profile